Aerie Pharmaceuticals Could Still Be a Bargain After Its Run-Up

Aerie Pharmaceuticals Could Still Be a Bargain After Its Run-Up·Motley Fool

Aerie Pharmaceuticals' potential to revolutionize glaucoma treatment could lead to blockbuster sales one day.

Advertisement